Management of immune checkpoint inhibitor–induced bullous pemphigoid

Management of immune checkpoint inhibitor–induced bullous pemphigoid

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American Academy of Dermatology 2021-02, Vol.84 (2), p.540-543
Hauptverfasser: Apalla, Zoe, Lallas, Aimilios, Delli, Florentina, Lazaridou, Elizabeth, Papalampou, Stavroula, Apostolidou, Stavroula, Gerochristou, Maria, Rigopoulos, Dimitrios, Stratigos, Alexandros, Nikolaou, Vassiliki
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 543
container_issue 2
container_start_page 540
container_title Journal of the American Academy of Dermatology
container_volume 84
creator Apalla, Zoe
Lallas, Aimilios
Delli, Florentina
Lazaridou, Elizabeth
Papalampou, Stavroula
Apostolidou, Stavroula
Gerochristou, Maria
Rigopoulos, Dimitrios
Stratigos, Alexandros
Nikolaou, Vassiliki
description
doi_str_mv 10.1016/j.jaad.2020.05.045
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2405301937</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0190962220309105</els_id><sourcerecordid>2405301937</sourcerecordid><originalsourceid>FETCH-LOGICAL-c466t-2da24e280faba2bf013bd6a88ee22db07b4b1a1641da8ee964326efd70aea7493</originalsourceid><addsrcrecordid>eNp9kM1OwzAQhC0EoqXwAhxQjlwS1o7jJBIXVFFAKuICZ8uON61L_ogTJG68A2_Ik-CqhSOnlUYzo52PkHMKEQUqrjbRRikTMWAQQRIBTw7IlEKehiLN0kMyBZpDmAvGJuTEuQ0A5DxOj8kkZpxlgsZTsnhUjVphjc0QtGVg63psMCjWWLx2rfWibdZW26Htvz-_bGPGAk2gx6pqRxd0WHdru2qtOSVHpaocnu3vjLwsbp_n9-Hy6e5hfrMMCy7EEDKjGEeWQam0YroEGmsjVJYhMmY0pJprqqjg1Civ5YLHTGBpUlCoUp7HM3K56-369m1EN8jaugKrSjXoP5KMQxL72XHqrWxnLfrWuR5L2fW2Vv2HpCC3_ORGbvnJLT8JifT8fOhi3z_qGs1f5BeYN1zvDOhXvlvspSssNp6K7bEYpGntf_0_TVqDNQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2405301937</pqid></control><display><type>article</type><title>Management of immune checkpoint inhibitor–induced bullous pemphigoid</title><source>Elsevier ScienceDirect Journals</source><creator>Apalla, Zoe ; Lallas, Aimilios ; Delli, Florentina ; Lazaridou, Elizabeth ; Papalampou, Stavroula ; Apostolidou, Stavroula ; Gerochristou, Maria ; Rigopoulos, Dimitrios ; Stratigos, Alexandros ; Nikolaou, Vassiliki</creator><creatorcontrib>Apalla, Zoe ; Lallas, Aimilios ; Delli, Florentina ; Lazaridou, Elizabeth ; Papalampou, Stavroula ; Apostolidou, Stavroula ; Gerochristou, Maria ; Rigopoulos, Dimitrios ; Stratigos, Alexandros ; Nikolaou, Vassiliki</creatorcontrib><identifier>ISSN: 0190-9622</identifier><identifier>EISSN: 1097-6787</identifier><identifier>DOI: 10.1016/j.jaad.2020.05.045</identifier><identifier>PMID: 32428613</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><ispartof>Journal of the American Academy of Dermatology, 2021-02, Vol.84 (2), p.540-543</ispartof><rights>2020 American Academy of Dermatology, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c466t-2da24e280faba2bf013bd6a88ee22db07b4b1a1641da8ee964326efd70aea7493</citedby><cites>FETCH-LOGICAL-c466t-2da24e280faba2bf013bd6a88ee22db07b4b1a1641da8ee964326efd70aea7493</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0190962220309105$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27903,27904,65309</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32428613$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Apalla, Zoe</creatorcontrib><creatorcontrib>Lallas, Aimilios</creatorcontrib><creatorcontrib>Delli, Florentina</creatorcontrib><creatorcontrib>Lazaridou, Elizabeth</creatorcontrib><creatorcontrib>Papalampou, Stavroula</creatorcontrib><creatorcontrib>Apostolidou, Stavroula</creatorcontrib><creatorcontrib>Gerochristou, Maria</creatorcontrib><creatorcontrib>Rigopoulos, Dimitrios</creatorcontrib><creatorcontrib>Stratigos, Alexandros</creatorcontrib><creatorcontrib>Nikolaou, Vassiliki</creatorcontrib><title>Management of immune checkpoint inhibitor–induced bullous pemphigoid</title><title>Journal of the American Academy of Dermatology</title><addtitle>J Am Acad Dermatol</addtitle><issn>0190-9622</issn><issn>1097-6787</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kM1OwzAQhC0EoqXwAhxQjlwS1o7jJBIXVFFAKuICZ8uON61L_ogTJG68A2_Ik-CqhSOnlUYzo52PkHMKEQUqrjbRRikTMWAQQRIBTw7IlEKehiLN0kMyBZpDmAvGJuTEuQ0A5DxOj8kkZpxlgsZTsnhUjVphjc0QtGVg63psMCjWWLx2rfWibdZW26Htvz-_bGPGAk2gx6pqRxd0WHdru2qtOSVHpaocnu3vjLwsbp_n9-Hy6e5hfrMMCy7EEDKjGEeWQam0YroEGmsjVJYhMmY0pJprqqjg1Civ5YLHTGBpUlCoUp7HM3K56-369m1EN8jaugKrSjXoP5KMQxL72XHqrWxnLfrWuR5L2fW2Vv2HpCC3_ORGbvnJLT8JifT8fOhi3z_qGs1f5BeYN1zvDOhXvlvspSssNp6K7bEYpGntf_0_TVqDNQ</recordid><startdate>202102</startdate><enddate>202102</enddate><creator>Apalla, Zoe</creator><creator>Lallas, Aimilios</creator><creator>Delli, Florentina</creator><creator>Lazaridou, Elizabeth</creator><creator>Papalampou, Stavroula</creator><creator>Apostolidou, Stavroula</creator><creator>Gerochristou, Maria</creator><creator>Rigopoulos, Dimitrios</creator><creator>Stratigos, Alexandros</creator><creator>Nikolaou, Vassiliki</creator><general>Elsevier Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202102</creationdate><title>Management of immune checkpoint inhibitor–induced bullous pemphigoid</title><author>Apalla, Zoe ; Lallas, Aimilios ; Delli, Florentina ; Lazaridou, Elizabeth ; Papalampou, Stavroula ; Apostolidou, Stavroula ; Gerochristou, Maria ; Rigopoulos, Dimitrios ; Stratigos, Alexandros ; Nikolaou, Vassiliki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c466t-2da24e280faba2bf013bd6a88ee22db07b4b1a1641da8ee964326efd70aea7493</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Apalla, Zoe</creatorcontrib><creatorcontrib>Lallas, Aimilios</creatorcontrib><creatorcontrib>Delli, Florentina</creatorcontrib><creatorcontrib>Lazaridou, Elizabeth</creatorcontrib><creatorcontrib>Papalampou, Stavroula</creatorcontrib><creatorcontrib>Apostolidou, Stavroula</creatorcontrib><creatorcontrib>Gerochristou, Maria</creatorcontrib><creatorcontrib>Rigopoulos, Dimitrios</creatorcontrib><creatorcontrib>Stratigos, Alexandros</creatorcontrib><creatorcontrib>Nikolaou, Vassiliki</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the American Academy of Dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Apalla, Zoe</au><au>Lallas, Aimilios</au><au>Delli, Florentina</au><au>Lazaridou, Elizabeth</au><au>Papalampou, Stavroula</au><au>Apostolidou, Stavroula</au><au>Gerochristou, Maria</au><au>Rigopoulos, Dimitrios</au><au>Stratigos, Alexandros</au><au>Nikolaou, Vassiliki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Management of immune checkpoint inhibitor–induced bullous pemphigoid</atitle><jtitle>Journal of the American Academy of Dermatology</jtitle><addtitle>J Am Acad Dermatol</addtitle><date>2021-02</date><risdate>2021</risdate><volume>84</volume><issue>2</issue><spage>540</spage><epage>543</epage><pages>540-543</pages><issn>0190-9622</issn><eissn>1097-6787</eissn><cop>United States</cop><pub>Elsevier Inc</pub><pmid>32428613</pmid><doi>10.1016/j.jaad.2020.05.045</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0190-9622
ispartof Journal of the American Academy of Dermatology, 2021-02, Vol.84 (2), p.540-543
issn 0190-9622
1097-6787
language eng
recordid cdi_proquest_miscellaneous_2405301937
source Elsevier ScienceDirect Journals
title Management of immune checkpoint inhibitor–induced bullous pemphigoid
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T00%3A57%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Management%20of%20immune%20checkpoint%20inhibitor%E2%80%93induced%20bullous%20pemphigoid&rft.jtitle=Journal%20of%20the%20American%20Academy%20of%20Dermatology&rft.au=Apalla,%20Zoe&rft.date=2021-02&rft.volume=84&rft.issue=2&rft.spage=540&rft.epage=543&rft.pages=540-543&rft.issn=0190-9622&rft.eissn=1097-6787&rft_id=info:doi/10.1016/j.jaad.2020.05.045&rft_dat=%3Cproquest_cross%3E2405301937%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2405301937&rft_id=info:pmid/32428613&rft_els_id=S0190962220309105&rfr_iscdi=true